US$ 20.15
tirzepatide for ulcerative colitis Five Things to Know About Weight-Loss Drugs and IBD Ischemic Colitis Associated With Tirzepatide
Description
Due to the popularity of this diabetes medication to help people lose weight, it opened the path for tons of other medications with a similar purpose to become available in the U.S

Diarrhea rates were 23% for Retatrutide versus 21% for Mounjaro

Fatigue accompanied by pallor, easy bruising, or unusual bleeding may indicate anaemia or other haematological conditions

It showed that patients treated with tirzepatide had significant reductions in LV mass and paracardiac adipose tissue compared to the placebo group

one 68-week, randomized, double-blind, placebo withdrawal trial

Optimizing glucose clearance, insulin sensitivity, and visceral fat reduction
